SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-24-000013
Filing Date
2024-03-12
Accepted
2024-03-12 18:04:43
Documents
1
Period of Report
2024-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1710281074.html 4  
1 FORM 4 wk-form4_1710281074.xml 4 13930
  Complete submission text file 0001739614-24-000013.txt   15416
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INHIBRX, INC. 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Eckelman Brendan P. (Reporting) CIK: 0001766433 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 24743796